Guardant Health, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $982.0 | $739.0 | $563.9 | $449.5 | $373.7 |
| Operating income | -$437.2 | -$443.6 | -$564.7 | -$544.4 | -$411.0 |
| Net income | -$416.3 | -$436.4 | -$479.4 | -$654.6 | -$384.8 |
| Cash Flow Statement | |||||
| Free cash flow | -$233.1 | -$274.9 | -$345.5 | -$386.9 | -$284.1 |
| Dividends | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| Share repurchases | $45.0 | $0.0 | $0.0 | — | — |
Shares outstanding 134.2M · Free float 69.2%
Annual filing data through FY ended December 31, 2025; float as of September 30, 2026.